Tempus AI (NASDAQ:TEM) Trading Down 4.4% on Insider Selling

Tempus AI, Inc. (NASDAQ:TEM) traded down 4.4% during trading on Friday following insider selling activity. The stock traded as low as $71.50 and last traded at $73.34. 5,496,515 shares were traded during trading, a decline of 61% from the average session volume of 14,108,693 shares. The stock had previously closed at $76.72.

Specifically, CFO James William Rogers sold 31,780 shares of the firm’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $82.33, for a total value of $2,616,447.40. Following the transaction, the chief financial officer now directly owns 189,320 shares in the company, valued at approximately $15,586,715.60. This trade represents a 14.37 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Erik Phelps sold 61,582 shares of the business’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $82.36, for a total transaction of $5,071,893.52. Following the transaction, the executive vice president now directly owns 153,080 shares of the company’s stock, valued at approximately $12,607,668.80. This represents a 28.69 % decrease in their position. The disclosure for this sale can be found here. In other Tempus AI news, CAO Ryan M. Bartolucci sold 818 shares of the company’s stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $81.87, for a total transaction of $66,969.66. Following the completion of the sale, the chief accounting officer now directly owns 46,182 shares in the company, valued at $3,780,920.34. This represents a 1.74 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on TEM shares. Stifel Nicolaus cut Tempus AI from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Loop Capital cut their price target on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a report on Tuesday, January 14th. Piper Sandler restated a “neutral” rating and issued a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Bank of America boosted their target price on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research report on Friday, December 13th. Finally, Wolfe Research began coverage on shares of Tempus AI in a report on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $58.55.

Tempus AI Trading Down 4.4 %

The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The stock’s 50 day moving average is $49.75 and its two-hundred day moving average is $51.44.

Institutional Trading of Tempus AI

Several institutional investors have recently bought and sold shares of TEM. Operose Advisors LLC acquired a new position in Tempus AI during the fourth quarter worth $25,000. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI in the 3rd quarter worth about $30,000. Farther Finance Advisors LLC acquired a new stake in shares of Tempus AI during the 4th quarter worth about $34,000. Prestige Wealth Management Group LLC lifted its holdings in Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after purchasing an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC acquired a new position in Tempus AI in the fourth quarter valued at about $49,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.